Literature DB >> 29439979

Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties.

Farhana Mosaddeque1,2, Shusaku Mizukami3, Mohamed Gomaa Kamel4,5, Awet Alem Teklemichael1,2, Truong Van Dat6, Satoshi Mizuta7, Dinh Van Toan6, Ali Mahmoud Ahmed4,8, Nguyen Lam Vuong4,6, Mohamed Tamer Elhady4,9, Hoang Thi Nam Giang4,10, Tran Ngoc Dang4,6,11, Michiko Fukuda1, Lam K Huynh12, Yoshimasa Tanaka7, Timothy J Egan13, Osamu Kaneko2,14,15, Nguyen Tien Huy16,3, Kenji Hirayama17,2,15.   

Abstract

The rapid spread of strains of malaria parasites that are resistant to several drugs has threatened global malaria control. Hence, the aim of this study was to predict the antimalarial activity of chemical compounds that possess anti-hemozoin-formation activity as a new means of antimalarial drug discovery. After the initial in vitro anti-hemozoin-formation high-throughput screening (HTS) of 9,600 compounds, a total of 224 hit compounds were identified as hemozoin inhibitors. These 224 compounds were tested for in vitro erythrocytic antimalarial activity at 10 μM by using chloroquine-mefloquine-sensitive Plasmodium falciparum strain 3D7A. Two independent experiments were conducted. The physicochemical properties of the active compounds were extracted from the ChemSpider and SciFinder databases. We analyzed the extracted data by using Bayesian model averaging (BMA). Our findings revealed that lower numbers of S atoms; lower distribution coefficient (log D) values at pH 3, 4, and 5; and higher predicted distribution coefficient (ACD log D) values at pH 7.4 had significant associations with antimalarial activity among compounds that possess anti-hemozoin-formation activity. The BMA model revealed an accuracy of 91.23%. We report new prediction models containing physicochemical properties that shed light on effective chemical groups for synthetic antimalarial compounds and help with in silico screening for novel antimalarial drugs.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antimalarial; drug; hemozoin; malaria; prediction

Mesh:

Substances:

Year:  2018        PMID: 29439979      PMCID: PMC5923155          DOI: 10.1128/AAC.02424-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.

Authors:  Rebecca D Sandlin; Melissa D Carter; Patricia J Lee; Jennifer M Auschwitz; Susan E Leed; Jacob D Johnson; David W Wright
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  The iron environment in heme and heme-antimalarial complexes of pharmacological interest.

Authors:  P A Adams; P A Berman; T J Egan; P J Marsh; J Silver
Journal:  J Inorg Biochem       Date:  1996-07       Impact factor: 4.155

3.  Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds.

Authors:  Nguyen Tien Huy; Dinh Thanh Uyen; Atsushi Maeda; Dai Thi Xuan Trang; Tatsuo Oida; Shigeharu Harada; Kaeko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

4.  Artemisinin resistance is a clear and present danger.

Authors:  Arjen M Dondorp; Pascal Ringwald
Journal:  Trends Parasitol       Date:  2013-06-12

5.  PEXEL-independent trafficking of Plasmodium falciparum SURFIN4.2 to the parasite-infected red blood cell and Maurer's clefts.

Authors:  Jean Semé Fils Alexandre; Kazuhide Yahata; Satoru Kawai; Motomi Torii; Osamu Kaneko
Journal:  Parasitol Int       Date:  2011-05-17       Impact factor: 2.230

6.  In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials.

Authors:  A K Tripathi; A Gupta; S K Garg; B L Tekwani
Journal:  Life Sci       Date:  2001-10-26       Impact factor: 5.037

7.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; José Francisco Fernandes; Béatrice Peggy Abossolo; Barbara Gaelle Nfono Ondo Methogo; Anita Lumeka Kabwende; Ayola Akim Adegnika; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Sonia Machevo; Sozinho Acacio; Helder Bulo; Betuel Sigauque; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Rose Minja; Maxmillian Mpina; Saumu Ahmed; Ali Mohammed Ali; Ali Takadir Mtoro; Ali Said Hamad; Paul Mutani; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Biébo Bihoun; Issa Guiraud; Berenger Kaboré; Olivier Sombié; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Martina Oneko; Chris Odero; Kephas Otieno; Norbert Awino; Meredith McMorrow; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Nekoye Otsyula; Stacey Gondi; Allan Otieno; Victorine Owira; Esther Oguk; George Odongo; Jon Ben Woods; Bernhards Ogutu; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Charity Maingi; Trudie Lang; Ally Olotu; Philip Bejon; Kevin Marsh; Gabriel Mwambingu; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; David Dosoo; Isaac Asante; George Adjei; Evans Kwara; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Coline Mahende; Edwin Liheluka; Lincoln Malle; Martha Lemnge; Thor G Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Anima Sarfo; Alex Agyekum; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Rutendo Nkomo; Tapiwa Tembo; Gerald Tegha; Mercy Tsidya; Jane Kilembe; Chimwemwe Chawinga; W Ripley Ballou; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Aurélie Olivier; Johan Vekemans; Terrell Carter; David Kaslow; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2012-11-09       Impact factor: 91.245

9.  HDP-a novel heme detoxification protein from the malaria parasite.

Authors:  Dewal Jani; Rana Nagarkatti; Wandy Beatty; Ross Angel; Carla Slebodnick; John Andersen; Sanjai Kumar; Dharmendar Rathore
Journal:  PLoS Pathog       Date:  2008-04-25       Impact factor: 6.823

10.  Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.

Authors:  Aung Pyae Phyo; Podjanee Jittamala; François H Nosten; Sasithon Pukrittayakamee; Mallika Imwong; Nicholas J White; Stephan Duparc; Fiona Macintyre; Mark Baker; Jörg J Möhrle
Journal:  Lancet Infect Dis       Date:  2015-10-05       Impact factor: 25.071

View more
  5 in total

1.  Phenylpropanoid-conjugated iridoid glucosides from leaves of Morinda morindoides.

Authors:  Yasinjan Hashim; Kazufumi Toume; Shusaku Mizukami; Toshinori Kitami; Mayumi Taniguchi; Awet Alem Teklemichael; Yuki Tayama; Nguyen Tien Huy; José Nzunzu Lami; Joseph M Bodi; Kenji Hirayama; Katsuko Komatsu
Journal:  J Nat Med       Date:  2021-09-17       Impact factor: 2.343

2.  Phenylpropanoid conjugated iridoids with anti-malarial activity from the leaves of Morinda morindoides.

Authors:  Yasinjan Hashim; Kazufumi Toume; Shusaku Mizukami; Yue-Wei Ge; Mayumi Taniguchi; Awet Alem Teklemichael; Nguyen Tien Huy; Joseph M Bodi; Kenji Hirayama; Katsuko Komatsu
Journal:  J Nat Med       Date:  2021-06-29       Impact factor: 2.343

3.  Magnetic Ligand Fishing Using Immobilized Cyclooxygenase-2 for Identification and Screening of Anticoronary Heart Disease Ligands From Choerospondias axillaris.

Authors:  Miaomiao Chi; Hongsen Wang; Zhankuan Yan; Lei Cao; Xun Gao; Kunming Qin
Journal:  Front Nutr       Date:  2022-01-31

4.  Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds.

Authors:  Awet Alem Teklemichael; Shusaku Mizukami; Kazufumi Toume; Farhana Mosaddeque; Mohamed Gomaa Kamel; Osamu Kaneko; Katsuko Komatsu; Juntra Karbwang; Nguyen Tien Huy; Kenji Hirayama
Journal:  Malar J       Date:  2020-06-08       Impact factor: 2.979

5.  Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases.

Authors:  Tomás Herraiz; Hugo Guillén; Diana González-Peña; Vicente J Arán
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.